Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

Ulutas Med J. 2021; 7(3): 203-208


Comparison of Pre-treatment and Post-treatment Auditory Brainstem Response Results in Children with Serous Otitis

Selman Sarica, Halil Ibrahim Argama, Serkan Kirik, Muhammet Bulut.




Abstract
Cited by 0 Articles

Introduction: The present study aimed to investigate the effect of middle ear effusion on the ABR test through a comparison of clinical auditory brainstem response (ABR) results in pre-treatment and post-treatment in patients diagnosed with otitis media with effusion (OME).
Materials and Methods: This retrospective study included 42 children aged 3 months-12 months, who failed the otoacoustic emissions (OAE) test in the hearing screening program and were diagnosed with serous otitis.
Results: Following treatment of the patients, the right ears of 76.9% of patients and the left ears of 69.04% of patients passed the distortion product otoacoustic emissions test. In the OAE tests post-treatment, in 23.8% of patients, the right ear, and 30.95% patients, the left ear was negative, and a decrease was seen in the hearing thresholds in clinical ABR. The latencies of the ABR 1st and 3rd waves were observed to be significantly prolonged pre-treatment compared to post-treatment in all patients.
Conclusion: The appropriate intervention in the early stage eliminates or reduces the negative effects of hearing loss. To avoid a very long follow-up period of infants diagnosed with serous otitis media in the first years of life, prompt treatment should be applied to patients who have not responded to medical treatment, and if the thresholds after treatment are above normal values, a hearing aid should be applied as soon as possible and family therapy should be provided.

Key words: Child, serous otitis, auditory brainstem response






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.